Home
Career Stage
Medical Students Residents Attendings CPT Codes Resources Blog Support

80280 Drug assay vedolizumab

Pathology & Lab

Also known as: vedolizumab level, Entyvio level

Laboratory quantitative drug assay for vedolizumab to assess serum level for therapeutic drug monitoring in inflammatory bowel disease treatment.

In Plain Language

vedolizumab blood test; biological medication level

Clinical Context

Monitors integrin antagonist vedolizumab levels in ulcerative colitis and Crohn's disease for optimization of therapeutic efficacy and antibody detection.

RVU Information

CPT 80280 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.

Billing & Documentation

Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.

How This Code Compares

This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.

Specialties

PathologyGastroenterologyInternal Medicine

Frequently Asked Questions

What is CPT code 80280?

CPT 80280 (Drug assay vedolizumab) is a Pathology & Lab code. Laboratory quantitative drug assay for vedolizumab to assess serum level for therapeutic drug monitoring in inflammatory bowel disease treatment.

Who uses CPT code 80280?

CPT 80280 is used by Pathology, Gastroenterology, Internal Medicine. Monitors integrin antagonist vedolizumab levels in ulcerative colitis and Crohn's disease for optimization of therapeutic efficacy and antibody detection.

When is CPT 80280 used?

Monitors integrin antagonist vedolizumab levels in ulcerative colitis and Crohn's disease for optimization of therapeutic efficacy and antibody detection.

Track This Code in RVU Edge

Log procedures, calculate wRVUs, and benchmark against national data — all in one app.

CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.